SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-007333
Filing Date
2021-01-12
Accepted
2021-01-12 17:07:54
Documents
14
Period of Report
2021-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70991d8k.htm   iXBRL 8-K 28894
2 EX-99.1 d70991dex991.htm EX-99.1 29168
6 GRAPHIC g70991g0112122539504.jpg GRAPHIC 3831
  Complete submission text file 0001193125-21-007333.txt   194319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210106.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210106_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210106_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d70991d8k_htm.xml XML 3271
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 21524172
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences